Good news in the midst of disaster: Russia to give India 100 million doses of coronavirus vaccine, trial to be successful in 2020 alone
The devastation of the corona virus is increasing rapidly in India. Meanwhile, there is good news that if all goes well, the Russian coronavirus vaccine could be given to India this year. A clinical trial of the world’s first corona vaccine, produced by Russia, could soon be launched in India. Russia’s Direct Investment Fund (RDIF) and the Indian company. Reddy Laboratories has a deal. Under the agreement, Russia will supply 100 million doses of the Sputnik-V vaccine to Indian companies.
But before that, clinical trials of this coronavirus vaccine in India may prove successful. The company will buy these supplies only after the successful trial of Sputnik-2 and the approval of Indian drug regulators.
GV Prasad, Managing Director, Reddy Laboratories, said in a statement, “We are pleased to partner with RDIF to bring the vaccine to India.” We will conduct a third phase trial in India for the approval of Indian regulators. The Sputnik-V vaccine could be a reliable alternative in the fight against India’s Covid-19.
RDIF President Kirill Dimitriev said the vaccine was based on an adenovirus vector platform. If the test is successful, the vaccine will be available in India later this year. He said that India is one of the most affected countries in the world by Corona. Let us know that on August 11 the Sputnik-V vaccine was recognized by the Russian Ministry of Health as the first vaccine against Kovid-19.